[1]
|
[1] Berger, S.L. (2007) The complex language of chromatin regulation during transcription. Nature, 447, 407-412.
doi:10.1038/nature05915
|
[2]
|
Hess-Stumpp, H., Bracker, T.U., Henderson, D. and Po- litz, O. (2007) MS-275, a potent orally available inhibitor of histone deacetylases—The development of an anti can- cer agent. The International Journal of Biochemistry & Cell Biology, 39, 1388-1405.
doi:10.1016/j.biocel.2007.02.009
|
[3]
|
Silverstein, R.A. and Ekwall, K. (2005) Sin3: A flexible regulator of global gene expression and genome stability. Current Genetics, 47, 1-17.
doi: 10.1007/s00294-004-0541-5
|
[4]
|
Li, J., Wang, J., Nawaz, Z., Liu, J.M., Qin, J. and Wong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. Embo Journal, 19, 4342-4350. doi:10.1093/emboj/19.16.4342
|
[5]
|
Gao, Z., Chiao, P., Zhang, X., Lazar, M.A., Seto, E., Young, H.A. and Ye, J. (2005) Coactivators and corepressors of NF-κB in IκBα gene promoter. Journal of Biological Chemistry, 280, 21091-21098.
doi:10.1074/jbc.M500754200
|
[6]
|
Riester, D., Hildmann, C. and Schwienhorst, A. (2007) Histone deacetylase inhibitors—Turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases. Applied Microbiological Biotechnology, 75, 499-514.
doi:10.1007/s00253-007-0912-1
|
[7]
|
Pulukuri, S.M., Gorantla, B. and Rao, J.S. (2007) Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. Journal of Biological Chemistry, 282, 35594-35603. doi: 10.1074/jbc.M705867200
|
[8]
|
Cretu, A., Sha, X., Tront, J., Hoffman, B. and Liebermann, D.A. (2009) Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Therapy, 7, 268-276.
|
[9]
|
Hoffman, B. and Liebermann, D.A. (2009) Gadd45 mo- dulation of intrinsic and extrinsic stress responses in mye- loid cells. Journal of Cell Physiology, 218, 26-31.
doi:10.1002/jcp.21582
|
[10]
|
Hatayama, H., Iwashita, J., Kuwajima, A. and Abe, T. (2007) The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochemical and Biophysical Research Com- munications, 356, 599-603.
doi:10.1016/j.bbrc.2007.03.025
|
[11]
|
Chen, Z., Clark, S., Birkeland, M., Sung, C.M., Lago, A., Liu, R., Kirkpatrick, R., Johanson, K., Winkler, J.D. and Hu, E. (2002) Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) α and β messenger RNAs by histone deacetylase inhibitors tricho- statin A (TSA) and butyrate in SW620 human colon carcinoma cells. Cancer Letters, 188, 127-140.
doi:10.1016/S0304-3835(02)00322-1
|
[12]
|
Zumbrun, S.D., Hoffman, B. and Liebermann, D.A. (2009) Distinct mechanisms are utilized to induce stress sensor gadd45β by different stress stimuli. Journal of Cell Biochemistry, 108, 1220-1231. doi:10.1002/jcb.22354
|
[13]
|
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N. and Horinouchi, S. (2001) Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemotherapy and Pharmacology, 48, S20-S26.
doi:10.1007/s002800100300
|
[14]
|
Iwashita, J., Yamamoto, T., Sasaki, Y. and Abe, T. (2010) MUC5AC production is downregulated in NCI-H292 lung cancer cells cultured on type-IV collagen. Molecular Cell Biochemistry, 337, 65-75.
doi: 10.1007/s11010-009-0286-z
|
[15]
|
Erisman, M.D., Rothberg, P.G., Diehl, R.E., Morse, C.C., Spandorfer, J.M. and Astrin, S.M. (1985) Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Molecular and Cellular Biology, 5, 1969-1976.
doi:10.1128/MCB.5.8.1969
|
[16]
|
Seoane, J., Le, H.V. and Massague, J. (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 419, 729-734. doi:10.1038/nature01119
|
[17]
|
Millau, J.F., Bastien, N., Bouchard, E.F. and Drouin, R. (2009) p53 pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter. Cancer Research, 69, 8463- 8471. doi: 10.1158/0008-5472.CAN-09-2036
|
[18]
|
Habold, C., Poehlmann, A., Bajbouj, K., Hartig, R., Korkmaz, K.S., Roessner, A. and Schneider-Stock, R. (2008) Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. Journal of Cellular and Molecular Medicine, 12, 607-621. doi:10.1111/j.1582-4934.2007.00136.x
|
[19]
|
Liu, P.Y., Chan, J.Y., Lin, H.C., Wang, S.L., Liu, S.T., Ho, C.L., Chang, L.C. and Huang, S.M. (2008) Modulation of the cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Molecular Cancer Research, 6, 1204-1214. doi:10.1158/1541-7786.MCR-08-0123
|
[20]
|
Ocker, M. and Schneider-Stock, R. (2007) Histone dea- cetylase inhibitors: signalling towards p21cip1/waf1. The International Journal of Biochemistry & Cell Biology, 39, 1367-1374. doi:10.1016/j.biocel.2007.03.001
|
[21]
|
Li, H. and Wu, X. (2004) Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Biochemical and Biophysical Research Communications, 324, 860-867. doi:10.1016/j.bbrc.2004.09.130
|
[22]
|
Schepeler, T., Mansilla, F., Christensen, L.L., Orntoft, T. F. and Andersen, C.L. (2007) Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling. Journal of Molecular Signaling, 2, 6.
doi:10.1186/1750-2187-2-6
|
[23]
|
Violette, S., Poulain, L., Dussaulx, E., Pepin, D., Faussat, A. M., Chambaz, J., Lacorte, J.M., Staedel, C. and Lesuffleur, T. (2002) Resistance of colon cancer cells to long- term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. International Journal of Cancer, 98, 498-504.
doi:10.1002/ijc.10146
|
[24]
|
Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W. and Vogelstein, B. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature, 362, 857-860. doi:10.1038/362857a0
|
[25]
|
Kearsey, J.M., Coates, P.J., Prescott, A.R., Warbrick, E. and Hall, P.A. (1995) Gadd45 is a nuclear cell cycle re- gulated protein which interacts with p21(Cip1). Oncogene, 11, 1675-1683.
|
[26]
|
Arvanitis, C. and Felsher, D.W. (2006) Conditional trans- genic models define how MYC initiates and maintains tu- morigenesis. Seminars in Cancer Biology, 16, 313-317.
doi:10.1016/j.semcancer.2006.07.012
|